(TSN) Tyson Foods - Ratings and Ratios
Beef, Pork, Chicken, Prepared Foods
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.31% |
| Yield on Cost 5y | 4.59% |
| Yield CAGR 5y | 3.68% |
| Payout Consistency | 91.7% |
| Payout Ratio | 48.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.2% |
| Value at Risk 5%th | 35.0% |
| Relative Tail Risk | -4.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.05 |
| Alpha | -4.97 |
| CAGR/Max DD | 0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.349 |
| Beta | 0.276 |
| Beta Downside | 0.110 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.91% |
| Mean DD | 12.26% |
| Median DD | 11.73% |
Description: TSN Tyson Foods December 19, 2025
Tyson Foods (NYSE:TSN) is a global food processor organized into four core segments-Beef, Pork, Chicken, and Prepared Foods-covering everything from live animal processing to value-added, ready-to-eat products sold under brands such as Jimmy Dean, Hillshire Farm, and Ball Park.
Key operational metrics: FY 2024 net sales topped $48 billion, with chicken contributing roughly 55 % of revenue; the company’s adjusted EBITDA margin hovered around 8 %, reflecting tight cost control despite volatile feed-grain prices. Tyson’s exposure to commodity inputs (corn, soy) makes grain-price inflation a primary driver of earnings, while rising protein demand in emerging markets supports long-term volume growth.
Distribution channels span grocery retailers, warehouse clubs, food-service operators, and military commissaries, giving Tyson a diversified revenue base that buffers against cyclical swings in any single outlet.
For a deeper quantitative view, you might explore Tyson’s metrics on ValueRay to see how these fundamentals translate into valuation signals.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (474.0m TTM) > 0 and > 6% of Revenue (6% = 3.27b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -0.72pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.48% (prev 9.31%; Δ -2.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 2.15b > Net Income 474.0m (YES >=105%, WARN >=100%) |
| Net Debt (7.60b) to EBITDA (2.58b) ratio: 2.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.55 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (348.0m) change vs 12m ago -2.52% (target <= -2.0% for YES) |
| Gross Margin 6.54% (prev 6.80%; Δ -0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 147.6% (prev 143.7%; Δ 3.93pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.71 (EBITDA TTM 2.58b / Interest Expense TTM 449.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.57
| (A) 0.10 = (Total Current Assets 9.92b - Total Current Liabilities 6.39b) / Total Assets 36.66b |
| (B) 0.51 = Retained Earnings (Balance) 18.65b / Total Assets 36.66b |
| (C) 0.03 = EBIT TTM 1.22b / Avg Total Assets 36.88b |
| (D) 1.00 = Book Value of Equity 18.50b / Total Liabilities 18.43b |
| Total Rating: 3.57 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.69
| 1. Piotroski 6.0pt |
| 2. FCF Yield 4.17% |
| 3. FCF Margin 2.16% |
| 4. Debt/Equity 0.49 |
| 5. Debt/Ebitda 2.95 |
| 6. ROIC - WACC (= -1.46)% |
| 7. RoE 2.59% |
| 8. Rev. Trend 50.12% |
| 9. EPS Trend -35.53% |
What is the price of TSN shares?
Over the past week, the price has changed by -2.40%, over one month by +11.19%, over three months by +10.07% and over the past year by +4.04%.
Is TSN a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 9
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.3 | 8.2% |
| Analysts Target Price | 63.3 | 8.2% |
| ValueRay Target Price | 64.3 | 10% |
TSN Fundamental Data Overview December 19, 2025
P/E Trailing = 43.6567
P/E Forward = 14.771
P/S = 0.3794
P/B = 1.136
P/EG = 0.3217
Beta = 0.463
Revenue TTM = 54.44b USD
EBIT TTM = 1.22b USD
EBITDA TTM = 2.58b USD
Long Term Debt = 7.92b USD (from longTermDebt, last quarter)
Short Term Debt = 909.0m USD (from shortTermDebt, last quarter)
Debt = 8.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.60b USD (from netDebt column, last quarter)
Enterprise Value = 28.25b USD (20.65b + Debt 8.83b - CCE 1.23b)
Interest Coverage Ratio = 2.71 (Ebit TTM 1.22b / Interest Expense TTM 449.0m)
FCF Yield = 4.17% (FCF TTM 1.18b / Enterprise Value 28.25b)
FCF Margin = 2.16% (FCF TTM 1.18b / Revenue TTM 54.44b)
Net Margin = 0.87% (Net Income TTM 474.0m / Revenue TTM 54.44b)
Gross Margin = 6.54% ((Revenue TTM 54.44b - Cost of Revenue TTM 50.88b) / Revenue TTM)
Gross Margin QoQ = 5.24% (prev 8.22%)
Tobins Q-Ratio = 0.77 (Enterprise Value 28.25b / Total Assets 36.66b)
Interest Expense / Debt = 1.20% (Interest Expense 106.0m / Debt 8.83b)
Taxrate = 14.71% (10.0m / 68.0m)
NOPAT = 1.04b (EBIT 1.22b * (1 - 14.71%))
Current Ratio = 1.55 (Total Current Assets 9.92b / Total Current Liabilities 6.39b)
Debt / Equity = 0.49 (Debt 8.83b / totalStockholderEquity, last quarter 18.09b)
Debt / EBITDA = 2.95 (Net Debt 7.60b / EBITDA 2.58b)
Debt / FCF = 6.46 (Net Debt 7.60b / FCF TTM 1.18b)
Total Stockholder Equity = 18.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.29% (Net Income 474.0m / Total Assets 36.66b)
RoE = 2.59% (Net Income TTM 474.0m / Total Stockholder Equity 18.33b)
RoCE = 4.64% (EBIT 1.22b / Capital Employed (Equity 18.33b + L.T.Debt 7.92b))
RoIC = 3.77% (NOPAT 1.04b / Invested Capital 27.52b)
WACC = 5.23% (E(20.65b)/V(29.48b) * Re(7.03%) + D(8.83b)/V(29.48b) * Rd(1.20%) * (1-Tc(0.15)))
Discount Rate = 7.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.99%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈1.29b ; Y1≈846.6m ; Y5≈387.1m
Fair Price DCF = 26.88 (DCF Value 7.61b / Shares Outstanding 283.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -35.53 | EPS CAGR: -21.64% | SUE: 3.66 | # QB: 2
Revenue Correlation: 50.12 | Revenue CAGR: 1.86% | SUE: -1.65 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.89 | Chg30d=-0.009 | Revisions Net=+1 | Analysts=9
EPS current Year (2026-09-30): EPS=3.85 | Chg30d=-0.054 | Revisions Net=+0 | Growth EPS=-6.6% | Growth Revenue=+2.6%
EPS next Year (2027-09-30): EPS=4.34 | Chg30d=-0.167 | Revisions Net=-3 | Growth EPS=+12.6% | Growth Revenue=+0.9%
Additional Sources for TSN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle